| 摘要 |
This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae I and III-XII, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae I and III-XII. |
| 申请人 |
INSPIRE PHARMACEUTICALS, INC.;DOUGLASS, JAMES G., III;PLOURDE, ROBERT, JR.;SHAVER, SAMMY R.;WATSON, PAUL S.;BOYER, JOSE L.;DECAMP, JONATHAN B.;SAMUELSON, CARL A. |
发明人 |
DOUGLASS, JAMES G., III;PLOURDE, ROBERT, JR.;SHAVER, SAMMY R.;WATSON, PAUL S.;BOYER, JOSE L.;DECAMP, JONATHAN B.;SAMUELSON, CARL A. |
